Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population
Thomas Vogl, Sigal Leviatan, Eran Segal
Cell Reports Medicine (2021) Vol. 2, Iss. 2, pp. 100191-100191
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Label-free impedimetric immunosensor for point-of-care detection of COVID-19 antibodies
Lian C. T. Shoute, Gaser N. Abdelrasoul, Yuhao Ma, et al.
Microsystems & Nanoengineering (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 37
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future
Fausto Baldanti, Nirmal Kumar Ganguly, Guiqiang Wang, et al.
Critical Reviews in Clinical Laboratory Sciences (2022) Vol. 59, Iss. 7, pp. 445-459
Open Access | Times Cited: 27
Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern
Courtney Voss, Sally Esmail, Xuguang Liu, et al.
JCI Insight (2021) Vol. 6, Iss. 13
Open Access | Times Cited: 39
Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer
Thomas Mueller
Clinica Chimica Acta (2021) Vol. 518, pp. 9-16
Open Access | Times Cited: 36
Using test positivity and reported case rates to estimate state-level COVID-19 prevalence and seroprevalence in the United States
Weihsueh A. Chiu, Martial L. Ndeffo-Mbah
PLoS Computational Biology (2021) Vol. 17, Iss. 9, pp. e1009374-e1009374
Open Access | Times Cited: 36
Coronavirus Disease 2019: Clinics, Treatment, and Prevention
Francesco Burkert, Lukas Lanser, Rosa Bellmann‐Weiler, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 28
Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG
Kirsten Alexandra Eberhardt, Felix Dewald, Eva Heger, et al.
Microorganisms (2021) Vol. 9, Iss. 4, pp. 733-733
Open Access | Times Cited: 24
Infection induced SARS-CoV-2 seroprevalence and heterogeneity of antibody responses in a general population cohort study in Catalonia Spain
Marianna Karachaliou, Gemma Moncunill, Ana Espinosa, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Diagnostic Tools for Rapid Screening and Detection of SARS-CoV-2 Infection
Satish Kumar Pandey, Girish C. Mohanta, Vinod Kumar, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1200-1200
Open Access | Times Cited: 15
Development of an Enzyme-Linked Immunosorbent Assay (ELISA) for Accurate and Prompt Coronavirus Disease 2019 (COVID-19) Diagnosis Using the Rational Selection of Serological Biomarkers
Theano Lagousi, John G. Routsias, Vana Spoulou
Diagnostics (2021) Vol. 11, Iss. 11, pp. 1970-1970
Open Access | Times Cited: 16
Affinity of anti-spike antibodies in SARS-CoV-2 patient plasma and its effect on COVID-19 antibody assays
Patrick J. Macdonald, Qiaoqiao Ruan, Jessica L. Grieshaber, et al.
EBioMedicine (2021) Vol. 75, pp. 103796-103796
Open Access | Times Cited: 16
Applications of time series analysis in epidemiology: Literature review and our experience during COVID-19 pandemic
L Tomov, Lyubomir Chervenkov, Dimitrina Miteva, et al.
World Journal of Clinical Cases (2023) Vol. 11, Iss. 29, pp. 6974-6983
Open Access | Times Cited: 6
Community-Based Seroprevalence of SARS-CoV-2 Antibodies following the First Wave of the COVID-19 Pandemic in Jazan Province, Saudi Arabia
Abdulaziz Alhazmi, Edrous Alamer, Siddig İbrahim Abdelwahab, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 23, pp. 12451-12451
Open Access | Times Cited: 12
Population differences in antibody response to SARS‐CoV‐2 infection and BNT162b2 vaccination
Guy Shapira, Ramzia Abu Hamad, Chen Weiner, et al.
The FASEB Journal (2022) Vol. 36, Iss. 4
Open Access | Times Cited: 8
A novel quantitative double antigen sandwich ELISA for detecting total antibodies against Candida albicans enolase 1
Lihui Wang, Zongzhong He, Yiyang Guo, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2024) Vol. 43, Iss. 9, pp. 1815-1823
Closed Access | Times Cited: 1
Screening of potential spike glycoprotein / ACE2 dual antagonists against COVID-19 in silico molecular docking
Ran Yu, Peng Li
Journal of Virological Methods (2021) Vol. 301, pp. 114424-114424
Open Access | Times Cited: 9
Evaluation of a new spike (S) protein based commercial immunoassay for the detection of anti-SARS-CoV-2 IgG
Kirsten Alexandra Eberhardt, Felix Dewald, Eva Heger, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 8
A statistical model for early estimation of the prevalence and severity of an epidemic or pandemic from simple tests for infection confirmation
Yuval Shaḥar, Osnat Mokryn
PLoS ONE (2023) Vol. 18, Iss. 1, pp. e0280874-e0280874
Open Access | Times Cited: 2
Analysis of SARS-CoV-2 antibody seroprevalence in Northern Ireland during 2020–2021
Michelle K. Greene, Peter Smyth, Andrew English, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24184-e24184
Open Access
Epidemiological contemplation for a currently pragmatic COVID-19 health passport: a perspective
Radha Ambalavanan, R Sterling Snead, Julia Marczika, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access
Snapshot of Anti-SARS-CoV-2 IgG Antibodies in COVID-19 Recovered Patients in Guinea
Solène Grayo, Houlou Sagno, Oumar Diassy, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 10, pp. 2965-2965
Open Access
Serum Anti-SARS-CoV-2 IgG in Chronic Hepatitis B Virus Positive Patients
Mohammad Mahadi Hasan Mazumder, Ifat Ara Begum, Mohammad Nurul Alam, et al.
Journal of Comilla Medical College Teachers Association (2024) Vol. 28, Iss. 1, pp. 19-23
Open Access
Outbreak of SARS-CoV-2 Cases during Omicron Variant Infections
Mohammed Muhsin, Alaa H. Fadhil, Asmaa Haseeb Hwaid, et al.
Iraqi Journal of Science (2024), pp. 4212-4219
Open Access
A longitudinal study of anti-SARS-CoV-2 antibody seroprevalence in a random sample of the general population in Hiroshima in 2020
Aya Sugiyama, Fumie Okada, Kanon Abe, et al.
Environmental Health and Preventive Medicine (2022) Vol. 27, pp. 30-30
Open Access | Times Cited: 3
Epitope-resolved serology test differentiates the clinical outcome of COVID-19 and identifies defects in antibody response in SARS-CoV-2 variants
Courtney Voss, Sally Esmail, Xuguang Liu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top